4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-24-008531
CEO bought 106,888 shares at an average $0.93 ($99,326)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2024-12-18 | Purchase | +100,000 | $0.93 | $93,210 | 1,167,275 | D |
| Vaddi Krishna CEO | 2024-12-19 | Purchase | +6,888 | $0.89 | $6,116 | 127,553 | I |
| Open-market purchases · 106,888 sh · avg $0.93 · $99,326 | |||||||
Loading xslF345X05/primarydocument.xml…